Ningbo Menovo Pharmaceutical Hits Day Low at CNY 31.07 Amid Price Pressure

Ningbo Menovo Pharmaceutical Co., Ltd. experienced a significant decline today, with the stock dropping by 9.99% and reaching an intraday low of CNY 31.07. This performance stands in contrast to the China Shanghai Composite, which saw a modest gain of 0.85% on the same day. Over the past week, Ningbo Menovo's stock has decreased by 5.85%, while the broader market index fell by 3.0%. However, the company has shown resilience in its longer-term performance, boasting a remarkable 79.52% increase over the past year, significantly outperforming the China Shanghai Composite's 7.41% gain. Despite the recent downturn, Ningbo Menovo has reported positive financial metrics, including a notable rise in net sales, which reached CNY 439.46 million. The company also achieved a high debtors turnover ratio of 4.99 times, indicating efficient management of receivables. With a market capitalization of CNY 8,201 million, Ningbo Menovo continues to navigate a challenging market landscape while maintaining a competitive position within the pharmaceuticals and biotechnology sector.